BULLISHWHALES
BullishWhales · Congress · Trade Detail
--MOODY'S CORP SENIOR MED TERM NOTE CLBL M/W 2.75% 07/15/2019 F ILING S TATUS : New S UBHOLDING O F : LISA BLUNT ROCHESTER REV TST UA Apr 02,2015 LISA BLUNT ROCHESTER TR D ESCRIPTION : MOODY'S CORP SENIOR MED TERM NOTE CLBL M/W 2.75% 07/15/2019
DemocratSenate

Lisa Blunt Rochester bought MOODY'S CORP SENIOR MED TERM NOTE CLBL M/W 2.75% 07/15/2019 F ILING S TATUS : New S UBHOLDING O F : LISA BLUNT ROCHESTER REV TST UA Apr 02,2015 LISA BLUNT ROCHESTER TR D ESCRIPTION : MOODY'S CORP SENIOR MED TERM NOTE CLBL M/W 2.75% 07/15/2019 (--)

Lisa Blunt Rochester (D-DE), a U.S. Senator, has disclosed 74 trades in MOODY'S CORP SENIOR MED TERM NOTE CLBL M/W 2.75% 07/15/2019 F ILING S TATUS : New S UBHOLDING O F : LISA BLUNT ROCHESTER REV TST UA Apr 02,2015 LISA BLUNT ROCHESTER TR D ESCRIPTION : MOODY'S CORP SENIOR MED TERM NOTE CLBL M/W 2.75% 07/15/2019 (--) since 2017, 19 purchases and 55 sales, worth an estimated $5.4M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Lisa Blunt Rochester bought $100,001 - $250,000 of MOODY'S CORP SENIOR MED TERM NOTE CLBL M/W 2.75% 07/15/2019 F ILING S TATUS : New S UBHOLDING O F : LISA BLUNT ROCHESTER REV TST UA Apr 02,2015 LISA BLUNT ROCHESTER TR D ESCRIPTION : MOODY'S CORP SENIOR MED TERM NOTE CLBL M/W 2.75% 07/15/2019 (--) on January 3, 2017. Since that trade, -- is up +0.00% against the S&P 500 up +286.33%, an outperformance of -286.33%.

Across these filings, Lisa Blunt Rochester has been a net seller of -- (a buy-to-sell ratio of 0.35). The most recent disclosed -- transaction shown was dated February 4, 2019. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

-- trades
74
Disclosed Vol
$5.4M
Buys
19
26%
Sells
55
74%
Buy / Sell
0.35
ratio
First → Last
2017–2019

Lisa Blunt Rochester's -- trades vs the price

-- is up +0.00% since Lisa Blunt Rochester bought on January 3, 2017, versus +286.33% for the S&P 500.

Performance since this trade

Price change since trade
+0.00%
S&P 500 change since trade
+286.33%
Outperformance vs S&P 500
-286.33%

All Lisa Blunt Rochester -- trades

TradedTypeSizeReturnEst. profit
February 4, 2019SELL$15,001 - $50,000N/A
February 4, 2019SELL$100,001 - $250,000N/A
February 4, 2019SELL$50,001 - $100,000N/A
February 4, 2019SELL$15,001 - $50,000N/A
February 4, 2019SELL$50,001 - $100,000N/A
February 4, 2019SELL$1,001 - $15,000N/A
February 4, 2019SELL$15,001 - $50,000N/A
February 4, 2019SELL$50,001 - $100,000N/A
February 4, 2019SELL$50,001 - $100,000N/A
February 4, 2019SELL$15,001 - $50,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Lisa Blunt Rochester & -- trading FAQ

Is it legal for Lisa Blunt Rochester to trade MOODY'S CORP SENIOR MED TERM NOTE CLBL M/W 2.75% 07/15/2019 F ILING S TATUS : New S UBHOLDING O F : LISA BLUNT ROCHESTER REV TST UA Apr 02,2015 LISA BLUNT ROCHESTER TR D ESCRIPTION : MOODY'S CORP SENIOR MED TERM NOTE CLBL M/W 2.75% 07/15/2019 (--) stock?

Yes. Members of Congress are allowed to trade individual stocks, including MOODY'S CORP SENIOR MED TERM NOTE CLBL M/W 2.75% 07/15/2019 F ILING S TATUS : New S UBHOLDING O F : LISA BLUNT ROCHESTER REV TST UA Apr 02,2015 LISA BLUNT ROCHESTER TR D ESCRIPTION : MOODY'S CORP SENIOR MED TERM NOTE CLBL M/W 2.75% 07/15/2019 (--), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.

When did Lisa Blunt Rochester buy --?

Lisa Blunt Rochester disclosed a purchase of $100,001 - $250,000 of MOODY'S CORP SENIOR MED TERM NOTE CLBL M/W 2.75% 07/15/2019 F ILING S TATUS : New S UBHOLDING O F : LISA BLUNT ROCHESTER REV TST UA Apr 02,2015 LISA BLUNT ROCHESTER TR D ESCRIPTION : MOODY'S CORP SENIOR MED TERM NOTE CLBL M/W 2.75% 07/15/2019 (--) on January 3, 2017, according to public STOCK Act filings.

How has -- performed since Lisa Blunt Rochester's trade?

Since Lisa Blunt Rochester bought -- on January 3, 2017, the stock is up +0.00%, versus +286.33% for the S&P 500 over the same period, an outperformance of -286.33%.

How many times has Lisa Blunt Rochester traded --?

Lisa Blunt Rochester has disclosed 74 -- trades since 2017 (19 purchases and 55 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional -- trades?

BullishWhales tracks every disclosed congressional trade in MOODY'S CORP SENIOR MED TERM NOTE CLBL M/W 2.75% 07/15/2019 F ILING S TATUS : New S UBHOLDING O F : LISA BLUNT ROCHESTER REV TST UA Apr 02,2015 LISA BLUNT ROCHESTER TR D ESCRIPTION : MOODY'S CORP SENIOR MED TERM NOTE CLBL M/W 2.75% 07/15/2019 (--) on the MOODY'S CORP SENIOR MED TERM NOTE CLBL M/W 2.75% 07/15/2019 F ILING S TATUS : New S UBHOLDING O F : LISA BLUNT ROCHESTER REV TST UA Apr 02,2015 LISA BLUNT ROCHESTER TR D ESCRIPTION : MOODY'S CORP SENIOR MED TERM NOTE CLBL M/W 2.75% 07/15/2019 congressional trading page, which aggregates filings across all members of Congress.

Lisa Blunt Rochester's -- tradesAll congressional filings for MOODY'S CORP SENIOR MED TERM NOTE CLBL M/W 2.75% 07/15/2019 F ILING S TATUS : New S UBHOLDING O F : LISA BLUNT ROCHESTER REV TST UA Apr 02,2015 LISA BLUNT ROCHESTER TR D ESCRIPTION : MOODY'S CORP SENIOR MED TERM NOTE CLBL M/W 2.75% 07/15/2019Lisa Blunt Rochester's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.

v1.0.30